ACH profile · all as-reported value updates

ACCENDRA HEALTH INC/VA/ (ACH) as-reported value updates

Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.

Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.

Rows publish only when the later filed value differs by at least 1.0% and at least $1,000,000, after dropping differences that match under the capped trailing-zero precision rule. The delta percent is delta divided by the larger absolute filed value. Values are annual standardized facts only; metrics whose differences fall below those thresholds or match the capped precision rule are not published as rows.

Ledger table figure

Metric	FY	Earliest XBRL-filed value	Currently on file	Difference	Difference %	Label	Filing links	Notes
Revenue RevenueFromContractWithCustomerExcludingAssessedTax	2023	10,333,967,000 filed 2024-02-20 · 10-K	2,552,572,000 filed 2026-02-20 · 10-K	-7,781,395,000	-75.30%	revised comparative figure	0001558370-24-001369 0001104659-26-018169	3 filed observations examined for this concept and period.
Revenue RevenueFromContractWithCustomerExcludingAssessedTax	2024	10,700,883,000 filed 2025-02-28 · 10-K	2,680,112,000 filed 2026-02-20 · 10-K	-8,020,771,000	-74.95%	revised comparative figure	0001558370-25-001940 0001104659-26-018169	2 filed observations examined for this concept and period.
Cash and cash equivalents CashAndCashEquivalentsAtCarryingValue	2024	49,382,000 filed 2025-02-28 · 10-K	27,572,000 filed 2026-02-20 · 10-K	-21,810,000	-44.17%	revised comparative figure	0001558370-25-001940 0001104659-26-018169	2 filed observations examined for this concept and period.
Operating cash flow NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	2010	244,583,000 filed 2011-02-25 · 10-K	143,183,000 filed 2013-02-22 · 10-K	-101,400,000	-41.46%	revised comparative figure	0001193125-11-047429 0001193125-13-071696	3 filed observations examined for this concept and period.
Cash and cash equivalents CashAndCashEquivalentsAtCarryingValue	2018	103,367,000 filed 2019-03-06 · 10-K	66,308,000 filed 2020-03-04 · 10-K	-37,059,000	-35.85%	revised comparative figure	0000075252-19-000037 0000075252-20-000021	2 filed observations examined for this concept and period.
Operating cash flow NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	2009	165,320,000 filed 2011-02-25 · 10-K	218,038,000 filed 2012-02-24 · 10-K	52,718,000	+24.18%	revised comparative figure	0001193125-11-047429 0001193125-12-077718	2 filed observations examined for this concept and period. Earliest observation is a comparative value in a later annual filing.
Gross profit GrossProfit	2018	1,366,963,000 filed 2019-03-06 · 10-K	1,070,526,000 filed 2020-03-04 · 10-K	-296,437,000	-21.69%	revised comparative figure	0000075252-19-000037 0000075252-20-000021	2 filed observations examined for this concept and period.
Operating income OperatingIncomeLoss	2023	104,508,000 filed 2024-02-20 · 10-K	133,231,000 filed 2026-02-20 · 10-K	28,723,000	+21.56%	revised comparative figure	0001558370-24-001369 0001104659-26-018169	3 filed observations examined for this concept and period.
Capital expenditures PaymentsToAcquirePropertyPlantAndEquipment	2024	210,865,000 filed 2025-02-28 · 10-K	170,286,000 filed 2026-02-20 · 10-K	-40,579,000	-19.24%	revised comparative figure	0001558370-25-001940 0001104659-26-018169	2 filed observations examined for this concept and period.
Operating income OperatingIncomeLoss	2018	-392,174,000 filed 2019-03-06 · 10-K	-352,346,000 filed 2020-03-04 · 10-K	39,828,000	+10.16%	revised comparative figure	0000075252-19-000037 0000075252-20-000021	2 filed observations examined for this concept and period.
Capital expenditures PaymentsToAcquirePropertyPlantAndEquipment	2023	190,870,000 filed 2024-02-20 · 10-K	172,375,000 filed 2026-02-20 · 10-K	-18,495,000	-9.69%	revised comparative figure	0001558370-24-001369 0001104659-26-018169	3 filed observations examined for this concept and period.
Operating income OperatingIncomeLoss	2024	-207,769,000 filed 2025-02-28 · 10-K	-217,730,000 filed 2026-02-20 · 10-K	-9,961,000	-4.57%	revised comparative figure	0001558370-25-001940 0001104659-26-018169	2 filed observations examined for this concept and period.
Revenue RevenueFromContractWithCustomerExcludingAssessedTax	2018	9,838,708,000 filed 2019-03-06 · 10-K	9,418,192,000 filed 2020-03-04 · 10-K	-420,516,000	-4.27%	revised comparative figure	0000075252-19-000037 0000075252-20-000021	2 filed observations examined for this concept and period.
Stockholders' equity StockholdersEquity	2024	565,226,000 filed 2025-02-28 · 10-K	586,364,000 filed 2026-02-20 · 10-K	21,138,000	+3.60%	revised comparative figure	0001558370-25-001940 0001104659-26-018169	2 filed observations examined for this concept and period.
Stockholders' equity StockholdersEquity	2023	924,166,000 filed 2024-02-20 · 10-K	945,304,000 filed 2026-02-20 · 10-K	21,138,000	+2.24%	revised comparative figure	0001558370-24-001369 0001104659-26-018169	3 filed observations examined for this concept and period.
Stockholders' equity StockholdersEquity	2022	945,604,000 filed 2023-02-28 · 10-K	966,742,000 filed 2026-02-20 · 10-K	21,138,000	+2.19%	revised comparative figure	0000075252-23-000010 0001104659-26-018169	4 filed observations examined for this concept and period.